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T cells undergo profound metabolic changes to meet
the increased energy demands of maintaining an
antiviral response. We postulated that differences
in metabolic reprogramming would shape the effi-
cacy of CD8 T cells mounted against persistent viral
infections.We found that the poorly functional PD-1hi
T cell response against hepatitis B virus (HBV) had
upregulated the glucose transporter, Glut1, an effect
recapitulated by oxygen deprivation to mimic the in-
trahepatic environment. Glut1hi HBV-specific T cells
were dependent on glucose supplies, unlike the
more functional cytomegalovirus (CMV)-specific
T cells that could utilize oxidative phosphorylation
in the absence of glucose. The inability of HBV-
specific T cells to switch to oxidative phosphoryla-
tion was accompanied by increased mitochondrial
size and lower mitochondrial potential, indicative
of mitochondrial dysfunction. Interleukin (IL)-12,
which recovers HBV-specific T cell effector function,
increased their mitochondrial potential and reduced
their dependence on glycolysis. Our findings suggest
that mitochondrial defects limit the metabolic plas-
ticity of exhausted HBV-specific T cells.INTRODUCTION
On average, humans are infected with around 8–12 different
persistent viruses during their lifetime (Virgin et al., 2009). Most
of these infections, like Epstein-Barr Virus (EBV) and cytomega-
lovirus (CMV), are benign in the vast majority of human hosts,Cell R
This is an open access article undand the antiviral T cell response is adapted to keeping the virus
at bay while limiting organ damage. Other chronic infections,
such as HIV, hepatitis C virus (HCV), and hepatitis B virus
(HBV), cannot be controlled by the T cell response once persis-
tence is established, often resulting in immunopathology and
serious sequelae.
An estimated 240 million people worldwide are chronically in-
fected with HBV, which is the leading cause of liver cirrhosis and
hepatocellular carcinoma. CD8 T cells are one of the critical
mediators of HBV clearance, by interferon (IFN)g-mediated
non-cytopathic mechanisms, possibly supported by direct cyto-
toxicity. However in chronic HBV infection, the pivotal anti-viral
CD8 T cell response is virtually absent. The few HBV-specific
T cells detectable are functionally exhausted, with expression
of multiple co-inhibitory receptors and poor effector function
(Ferrari, 2015), a state that has recently been suggested to allow
them to adapt to the onslaught of high-dose antigen (Staron
et al., 2014; Utzschneider et al., 2013).
In contrast, T cells directed against CMV are a prototype of a
functional response able to efficiently contain this highly preva-
lent, persistent viral infection. CMV-specific T cells can readily
be detected in greatly expanded numbers, with conserved clo-
notypes often dominating the endogenous T cell repertoire
(Khan et al., 2002). They are phenotypically distinct, expressing
late differentiation markers such as KLRG-1 rather than the
multiple co-inhibitory receptors characteristic of HBV-specific
T cells (Schurich and Henson, 2014). CMV-specific T cells
produce significant amounts of effector cytokines such as
IFNg and tumor necrosis factor (TNF) in response to stimulation
with their cognate peptide in vitro.
Since HBV- andCMV-specific T cells are both directed against
persistent viruses but differ markedly in their functionality and
phenotype, we were interested in comparing their underlying
metabolic requirements. It is increasingly recognized that
adequate nutrient supply and energy production are keyeports 16, 1243–1252, August 2, 2016 ª 2016 The Author(s). 1243
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determinants of the capacity of T cells to proliferate and mediate
effector function (Pearce and Pearce, 2013). Naive and resting
T cells make use of fatty acid oxidation and the mitochondrial
tricarboxylic acid (TCA) cycle, which provides reducing agents
for energy production through oxidative phosphorylation
(OXPHOS) (Pearce et al., 2009). Recently, it has been shown in
murine models that mitochondrial activity is also needed for
activating and maintaining antigen-specific responses (Okoye
et al., 2015; Sena et al., 2013). Upon activation, CD8 T cells
have been described to switch their metabolism to become
heavily dependent on glycolysis, even in the presence of suffi-
cient oxygen. Despite being less energy efficient, glycolysis
provides fast energy and metabolites to support proliferation
and effector function (MacIver et al., 2013).
Many recent advances in the understanding of T cell meta-
bolism in naive, effector, and memory stages have been made
(Pearce and Pearce, 2013). However, the current knowledge of
T cell metabolism in chronic viral infections is essentially limited
to a single example, the murine model of LCMV (lymphocytic
choriomeningitis virus) (Schurich and Henson, 2014). Here, we
examine the metabolic requirements and restrictions of ex-
hausted HBV-specific CD8 T cells to the more functional CMV-
specific T cells within the same patients. Our data show that
CD8 T cells specific for these two chronic viral infections have
distinct metabolic profiles. CMV-specific T cells can fuel their en-
ergetic demands by making use of both glycolysis and OXPHOS
to exert full effector functions. In contrast, exhausted HBV-spe-
cific T cells show an impaired capacity to utilize mitochondrial
energy supply (OXPHOS), causing a dependence on glycolysis.
Their defect in mitochondrial metabolism is rescued by the pro-
inflammatory cytokine interleukin (IL)-12, which can stimulate a
recovery in HBV-specific effector function (Schurich et al.,
2013). Our data suggest that full effector function in human-vi-
rus-specific CD8 T cells is dependent on energy supply through
both OXPHOS and glycolysis.
RESULTS
Glut1 Expression Is Higher in CD8 T Cells Directed
against HBV Than CMV
Upon TCR (T cell receptor) stimulation, T cells markedly increase
the expression of de-novo-synthesized glucose transporter 1
(Glut1) to facilitate glucose uptake; this correlates with an in-
crease in glycolysis (Pearce and Pearce, 2013). To examine the
capacity for glucose uptake by human-virus-specific CD8
T cells, we analyzed their expression of Glut1 upon activation.
First, we stimulated T cells from chronically co-infected patients
with HBV- or CMV-derived peptides for 4 hr directly ex vivo and
measured Glut1 expression on dextramer-positive T cells. Glut1
expression was higher in activated virus-specific than in global
CD8 T cells (data not shown). Glut1 expression was increased
in HBV- compared to CMV-specific T cells (Figure 1A), suggest-
ing that a defect in glucose uptake was unlikely to be responsible
for their defective cytokine production (Figure S1A).
Since HBV-specific T cells from the circulation can only be
detected at very low frequency, we next expanded T cells in
culture to study their metabolic phenotype in more detail. We
confirmed that the differences observed ex vivo were main-1244 Cell Reports 16, 1243–1252, August 2, 2016tained in vitro. HBV- or CMV-specific CD8 cells were stimulated
with their cognate peptides and, upon restimulation, identi-
fied by their production of IFNg and co-stained for Glut1.
Again, the frequency of Glut1 expression in virus-specific
T cells was significantly increased above the amount ex-
pressed by the global CD8 cells in the same sample, confirming
that Glut1 is upregulated upon antigen-specific activation (Fig-
ures 1B and 1C).
We then compared paired HBV- and CMV-specific CD8 T cell
responses from the same donors, which had been activated to
comparable levels as assessed by CD38 expression (Fig-
ure S1B). The frequency of Glut1-positive cells was, again,
higher for HBV-specific than for CMV-specific CD8 in these
paired samples (Figures 1B and 1D). We observed the same
increased expression of Glut1 in HBV compared to CMV, when
cultured T cells were detected by dextramer staining in three pa-
tients with known responses to both viruses (Figure S1C).
To confirm that increased Glut1 expression was mediating
increased glucose uptake, we pulsed virus-specific T cells with
the fluorescent glucose analog 2-NBDG at the end of culture.
Increased expression of Glut1 was accompanied by an increase
in the uptake of 2-NBDG (Figures 1E and 1F; correlation in
Figure S1D).
Glut1 Upregulation Is Associated with T Cell Exhaustion
and Can Be Promoted by Hypoxic Conditions Mimicking
the Hepatic Milieu
Since the increased Glut1 expression and glucose uptake on
poorly functional HBV-specific CD8 was paradoxical, we
postulated that it might relate to their site of antigen encounter
in vivo. HBV only replicates in the liver, an immune suppressive
environment where T cells have restricted supplies of oxygen
(Jungermann and Kietzmann, 2000). Glut1 expression was,
indeed, increased in paired patient-derived CD8 T cells from
liver biopsies compared to PBMCs (peripheral blood mononu-
clear cells) directly ex vivo. In one HLA-A2+ patient, we de-
tected HBV-specific CD8 T cells, confirming increased Glut1
in the liver compared to the periphery (Figures 2A and 2B).
Next, we recapitulated the hypoxic environment in vitro by
stimulating HBV- and CMV-specific T cells in normoxic versus
hypoxic conditions (5% oxygen to mimic the concentration in
the hepatic circulation; Jungermann and Kietzmann, 2000).
Glut1 expression was promoted in hypoxic conditions (Fig-
ure 2C), an effect that was independent of the amount of
T cell proliferation (Figure S2A). It is, therefore, possible that a
phenotype favoring glycolysis might represent a feedback
response promoted by the hepatic environment in which
T cells encounter their antigen.
A hallmark of exhaustion is the co-inhibitory receptor PD-1
(Wherry, 2011), which is highly expressed on HBV-specific
T cells (Ferrari, 2015). We found that, even during culture,
HBV-specific CD8 maintained higher levels of PD-1, accompa-
nied by lower expansion and reduced production of IFNg+,
than CMV-specific CD8 (Figures S2B and S2C) (Schurich et al.,
2013). This is consistent with recent work showing that the
exhausted phenotype is stable (Utzschneider et al., 2013).
Antigen-stimulated HBV responses showed a correlation be-
tween their expression of PD-1 andGlut1 (Figure 2D), suggesting
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Figure 1. Increased Expression of Glut-1 on HBV-Specific Compared to CMV-Specific CD8 T Cells
(A) Glut1 expression in HBV- and CMV-specific T cells after 4-hr stimulation with cognate peptide directly ex vivo. Example of virus-specific cells detected by
staining with HLA-A2+ dextramers loaded with virus-specific or irrelevant control peptides (left), overlay of Glut1MFI in HBV- and CMV-specific cells (middle), and
summary data (right).
(B) Glut1 expression in global CD8 T cells (left), IFNg response upon culture with HBV- or CMV-specific peptides (middle), and Glut1 expression on virus-specific
IFNg CD8 T cells (right).
(C and D) Summary data comparing percentage of Glut1+ T cells in global and HBV-specific CD8 T cells (C) and HBV- and CMV-specific T cells (D) in paired
samples.
(E and F) Comparison of Glut1 expression and 2-NBDG uptake in IFNg+ HBV- and CMV-specific CD8 T cells, example (E) and summary data (F).
*p < 0.05; **p < 0.005; ***p < 0.0005.that exhausted T cells increase Glut1 expression. Furthermore,
we found a significant inverse correlation between Glut1 expres-
sion and the magnitude of T cell expansion, so that HBV-specificcells from patients with the lowest frequency responses
expressed the highest levels of Glut1 (Figure 2E). This did not
apply to CMV-specific T cells, for which there was no significantCell Reports 16, 1243–1252, August 2, 2016 1245
HBV-specific CMV-specific
Glut1
%
 o
f M
ax
5% 02
21% 02 normoxia hypoxia
0
1000
2000
3000
4000
G
lu
t1
M
FI
 in
 IF
N
γ+
normoxia hypoxia
0
1000
2000
3000
4000
G
lu
t1
M
FI
 in
 IF
N
γ +
HBV-specific CMV-specific
* *
A
C
D
G H
E F
B
Figure 2. CD8 T Cell Glut1 Expression Can Be Induced by Hypoxia and Correlates with an Exhausted Phenotype
(A) Glut1 expression in HBV-specific CD8 T cells, detected by HLA-A2 dextramer staining in paired PBMC and intrahepatic lymphocytes (IHL) directly ex vivo,
gated for CD3+CD8+CD4- T cells.
(legend continued on next page)
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correlation between Glut1 and magnitude of response in culture
(Figure 2F).
To further probe the metabolic phenotype of patient-derived
T cells, we measured cellular oxygen consumption rates
(OCRs) during a mitochondrial stress test. The extremely low
circulating frequency of HBV-specific T cells precluded their
use for this type of biochemical analysis. PD-1 is expressed
on recently activated, and maintained on exhausted, CD8
T cells in chronic viral infections (Barber et al., 2005), including
HBV (Boni et al., 2007; Fisicaro et al., 2010; Schurich et al.,
2013). Studying the impact of PD-1 on global CD8 T cell meta-
bolism in patients with persistent viral infections is important,
since therapeutic blockade of this pathway (currently consid-
ered in HBV following recent successes in cancer) will affect
all PD-1+ cells. Therefore, we sorted PD-1+ and PD-1 CD8
T cells and found that both fractions utilized glycolysis and
OXPHOS—as measured, respectively, by their extracellular
acidification rate (ECAR) and OCR—to varying degrees in the
three patients tested (Figure S2D). However, the spare respira-
tory capacity (SRC), calculated as percent change in
mean OCR at baseline to maximal OCR upon treatment with
FCCP (fluorocarbonyl cyanide phenylhydrazone), was lower in
PD-1+ compared to PD-1 CD8 T cells (Figures 2G and 2H),
a feature retained when cultured in vitro (Figure S2E). SRC is
a measure of maximal mitochondrial capacity available to a
cell (Henson et al., 2014); therefore, the low SRC suggests
that PD-1+ T cells are less well equipped to function in condi-
tions of increased energy demand. The low SRC in PD-1+ cells
was at odds with the higher abundance of memory cells in
this population (Figure S2F), described to be high utilizers of
OXPHOS (van der Windt et al., 2012). Our findings, therefore,
reinforced the potential relevance of PD-1 expression, rather
than T cell differentiation state, as a driver of the metabolic
changes observed.
HBV-Specific T Cells Are Dependent on Glycolysis for
Immediate Effector Function
To further examine the paradoxical increase in glucose uptake
by exhausted HBV-specific T cells, we tested their dependence
on glycolysis to provide energy. To this end, we stimulated
T cells in media containing galactose instead of glucose to
prevent them efficiently utilizing glycolysis (Chang et al., 2013).
After expansion in regular media, cells were split into either
glucose- or galactose-containing media to assess the require-
ment for glycolysis for immediate effector function upon anti-
genic restimulation.(B) Summary data of Glut1 expression on global CD8 T cells from PBMCs and IH
(C) PBMCs were cultured and restimulated with specific peptides on day 10 for 16
fluorescence intensity (MFI) in HBV- and CMV-specific T cells.
(D–F) Glut1 MFI was plotted against expression of (D) co-inhibitory PD-1, (E) per
(G) Oxygen consumption rates (OCRs) of purified patient-derived PD-1+ and PD-
anti-CD3 and IL-2 at the time of analysis, and mitochondrial inhibitors were added
the amount of oxygen utilized for ATP synthesis; FCCP uncouples ATP synthesi
mitochondrial membrane, allowing the calculation of the spare respiratory capa
blocking complexes I and III). neg, negative.
(H) The spare respiratory capacity (SRC) was calculated as percent change in me
patients tested in two independent experiments.
*p < 0.05.CMV-specific cells showed a diverse response to glucose
deprivation, with IFNg production in some patients being
completely unaffected, or even increased, and in others being
decreased (Figures 3A and B). Overall, the frequency of IFNg+
CMV-specific CD8 in the presence of galactose, compared
to glucose, was slightly reduced, while, the amount of IFNg pro-
duced per cell was unaffected (Figure S3A). In contrast, the IFNg
response of HBV-specific cells declined strikingly upon culture in
galactose (Figures 3A and 3B), with IFNg MFI (mean fluores-
cence intensity) also decreasing (Figure S3A). Thus, HBV-spe-
cific CD8 showed significantly more dependence on glycolysis
than CMV-specific CD8 when mounting an immediate effector
response (Figure 3B). Similarly, the frequency of T cells able
to produce TNF upon peptide restimulation in galactose was
more affected in HBV-specific than CMV-specific responses
(Figure 3C).
Next, we asked whether there was an association between
Glut1 expression and the ability of virus-specific cells to mediate
effector function in the absence of glucose. Therefore, we split
our cohort into patients for whom the response was more
severely affected (reduction in IFNg frequency below the mean
of the cohort; gray shaded area in Figure 3B) and those for
whom the response remained above the mean of the cohort.
HBV-specific responses most affected by blocking glycolysis
had significantly more Glut1+ cells then those that were less
affected, while a non-significant difference was observed for
CMV-specific cells (Figure S3B). These data suggest that the
upregulation of Glut1 reflects a dependence on glycolysis in
exhausted T cells.
The finding that HBV-specific T cells were unable to utilize
OXPHOS for effector function prompted us to investigate
whether they had a mitochondrial defect. Mitochondrial mass
(MM) can be assessed by staining cells with the mitochondrial-
potential-independent dye MitoTracker green, previously used
to assess the presence of enlarged non-functional mitochondria
in T cells (Henson et al., 2014). HBV-specific CD8 showed a
higher MM compared to CMV-specific CD8 from the same
donors (Figure 3D). The increased MM in HBV- compared to
CMV-specific CD8 was also apparent ex vivo (Figure 3E).
We then used the ratiometric fluorescent dye JC-1 to assess
mitochondrial potential, a key readout of mitochondrial function.
HBV-specific T cells showed a much lower mitochondrial poten-
tial than CMV-specific cells, as indicated by the drop in the red/
green fluorescence intensity ratio of the probe, which is indepen-
dent of mitochondrial size or shape (Figure 3F). A decrease in
mitochondrial potential could be a sign of apoptosis induction;L.
hr in hypoxic (5% O2) or normoxic (21% O2) conditions to analyze Glut1 mean
cent IFNg+ HBV-specific T cells, and (F) percent IFNg+ CMV-specific T cells.
1 CD8 T cells were measured in real-time ex vivo. Cells were stimulated with
as indicated (oligomycin is used to block mitochondrial complex V, indicating
s from the electron transport chain by transporting electrons across the inner
city; and rotenone/antimycin A finally shut down mitochondrial respiration by
an baseline OCR to mean maximal OCR after the addition of FCCP in the three
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however, we found HBV- and CMV-specific T cells to be viable,
as they were negative for dead-cell staining and showed low an-
nexin V staining, comparable to global T cells in the same culture
(Figure S3C). This indicates that mitochondrial dysfunction in
HBV-specific T cells limits their capacity to fuel their energy de-
mand for cytokine production by switching to OXPHOS.
The Third Signal Cytokine IL-12 Enhances theMetabolic
Function of Exhausted HBV-Specific T Cells
Recently, we demonstrated that the third signal pro-inflamma-
tory cytokine IL-12 enhanced effector responses in exhausted
HBV-specific T cells, while it had little effect on the functional
CMV-specific response. When HBV-specific T cells were stimu-
lated with viral peptide in the presence of IL-12, IFNg production,
TNF production, and cytotoxicity were significantly increased
(Schurich et al., 2013). We postulated that the capacity of IL-12
to reconstitute HBV-specific T cell effector function might be
mediated by a change in the efficiency of their glucose
metabolism.
To test this, we stimulated and cultured T cells in the presence
or absence of IL-12 and restimulated in the presence of either
glucose or galactose. When IL-12 enhanced IFNg production
by HBV-specific T cells, the cytokine did so regardless of
whether the cells were restimulated in glucose or galactose (Fig-
ures 4A and 4B). Furthermore, IL-12-stimulated HBV-specific
CD8 had a significantly increased ratio of polarized, compared
to depolarized, mitochondria (Figure 4C). These findings indicate
that IL-12 can stimulate mitochondrial and metabolic changes in
exhausted HBV-specific T cells, reversing their dependence on
glycolysis for effector function.
DISCUSSION
Glycolysis, accompaniedby theupregulationof theglucose trans-
porter Glut1, has been described to be the main metabolic
pathway fueling effector function upon T cell activation (MacIver
et al., 2013). Surprisingly, we found that exhausted HBV-specific
T cells, which have very limited effector capacity, showed a
marked increase in expression of functional Glut1 upon antigenic
stimulation, suggesting that their impaired effector function was
not due to a lack of glucose uptake. In contrast to HBV-specific
CD8, analysis of paired samples revealed that themore functional
CMV-specific CD8 expressed less Glut1, despite equivalent
levels of antigenic reactivation. This implied that HBV- and
CMV-specific T cells might utilize different metabolic pathways.
We tested this hypothesis by culturing the cells in galactose,
which impairs glycolysis, to probe the capacity of cells to useFigure 3. CMV-Specific, but Not HBV-Specific, CD8 T Cells Can Maint
(A–C) We cultured PBMCs in complete T cell media before transferring them into
restimulation. Representative example (A) and summary data showing the magnit
fold reduction compared to response in glucose (set to 1, indicated as a line in the
are indicated with dots.
(D and E) Comparison of MM in cultured HBV- and CMV-specific T cells by MitoT
dextramer+ virus-specific T cells ex vivo after 4-hr stimulation with cognate pep
(F) Determination of mitochondrial polarization state by staining with the ratiomet
red fluorescence shows depolarization. Example fluorescence-activated cell so
chondria in HBV- and CMV-specific T cells from the same patients.
**p < 0.005.the alternative pathway of generating energy via mitochondrial
OXPHOS (Chang et al., 2013).We found that HBV- andCMV-spe-
cific T cells are differentially affected by this method of favoring
OXPHOS over glycolysis. CMV-specific CD8 T cells from many
patients produced normal, or even elevated, amounts of effector
cytokines upon culture in galactose, while, in others, the produc-
tion declined but was never completely abrogated. These data
do not contradict previous findings regarding the importance
of glycolysis for IFNg production in CD4 T cells (Chang et al.,
2013). In HBV-specific cells, effector cytokine production
declined orwas completely lost. Defects in the glycolytic pathway
cannot be formally excluded, but our data indicate that exhausted
HBV-specific T cells rely on generating their energy through
glycolysis and cannot compensate by using other pathways.
Our findings indicate that, in some virus-specific effector T cells,
mitochondrial respiration isused tosupplementglycolysis inorder
to satisfy the demands of efficient cytokine production, in linewith
increased proliferation, survival, and anti-viral function in CD8
T cells with genetically enhanced OXPHOS (Okoye et al., 2015).
The generation of reactive oxygen species (ROS) is vital in the
activation of CD4 T cells (Sena et al., 2013), and an inability of
HBV-specific T cells to use OXPHOS could partially be due to
changes inROSproduction.However,wedidnot finda significant
difference in the production of ROS in exhausted, compared to
functional, CD8 (data not shown).
The observed inability of HBV-specific CD8 T cells to use
OXPHOS to fuel their effector function pointed to amitochondrial
defect. This was supported by their increased mitochondrial
depolarization compared to that of CMV-specific T cells, indica-
tive of impaired function. Additionally, an increase in MM in HBV-
specific, compared to CMV-specific, CD8 T cells could be due to
the formation of non-functional giant mitochondria, as have been
described to accumulate in terminally differentiated human CD8
T cells (Henson et al., 2014).
We found that the most exhausted T cells, as measured by
decrease in cytokine production and increase in co-inhibitory
PD-1, showed the highest expression of Glut1 and the lowest
ability to maintain effector functions when forced to use
OXPHOS. Our data, therefore, reveal that functional exhaustion
is linked to metabolic impairments in human-virus-specific
CD8 T cells. This link is underscored by the impact of IL-12; its
capacity to rescue HBV-specific CD8 T cells from exhaustion
and enhance their functionality (Schurich et al., 2013) is paral-
leled by an increased proportion of cells harboring polarized
mitochondria and a reduction in their dependence on glycolysis.
Of note, we have previously shown that IL-12 can reduce PD-1
expression on CD8 T cells (Schurich et al., 2013), and theain Effector Cytokine Production when Glucose Is Withdrawn
media containing either 10 mM glucose or 10 mM galactose for 24 hr before
ude of the virus-specific (B) IFNg and (C) TNF response in galactose, plotted as
graphs). Mean response is indicated with gray bars, and individual responses
racker Green staining, representative histograms, and summary data (D) and in
tide; representative histograms and summary data (E).
ric dye JC-1. Red JC-1 staining indicates polarized mitochondria, while loss of
rting (FACS) plot and comparison of the ratio of polarized/depolarized mito-
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Figure 4. Stimulation with the Pro-inflammatory Cytokine IL-12 Recovers HBV-Specific Responses even when Glycolysis Is Suppressed
(A) PBMCs were stimulated with HBV-derived peptides in the presence or absence of IL-12, cultured for 9 days, and transferred into media containing either
10mMglucose or 10mMgalactose for 24 hr before peptide restimulation for functional analysis. Representative FACS plots of the percentage of IFNg+CD8 cells
when cultured in glucose or galactose and stimulated with HBV peptides, with or without IL-12, or IL-12 alone.
(B) Summary data showing the IFNg response to HBV peptides in galactose alone, galactose with IL-12, or glucose with IL-12, plotted as the fold change
compared to the response of cells stimulated in glucose alone (set to 1, indicated as line in the graph). The mean response is indicated with gray bars, and
individual responses are indicated with dots.
(C) Change inmitochondrial polarization upon stimulation of HBV-specific T cells with IL-12, representative staining with JC-1 (left), and summary data comparing
the ratio of polarized to depolarized mitochondria (right).
*p < 0.05; **p < 0.005.contribution of this pathway to the metabolic changes observed
is currently under investigation.
Global patient-derived PD-1+ CD8 T cells had a low SRC,
suggesting that their ability to generate additional energy
through oxygen consumption in situations of metabolic stress
is reduced. PD-1 signaling has previously been described to
reduce glycolysis and promote fatty acid oxidation in global
CD4 T cells (Patsoukis et al., 2015), but the impact of PD-1
signaling on the metabolism of exhausted CD8 cells remains to
be investigated. It is also important to keep in mind that T cells
in patients with chronic HBV express additional inhibitory mole-
cules like Tim-3 and CTLA-4 (Nebbia et al., 2012; Schurich et al.,
2011); therefore, multiple signals might shape the altered meta-
bolism in these cells.
It will be interesting to establish whether exhausted T cells in
other settings (HIV or HCV infection, tumors) have a similar defi-
ciency in their capacity to supplement glycolysis with OXPHOS
in order to optimize their energy supply. The mitochondrial de-
fects and adaptation to glycolysis that we documented here
may be the result of particular features of chronic HBV, such
as high-level antigenic stimulation in the immunosuppressive
liver environment. In particular, the hypoxic milieu of the liver1250 Cell Reports 16, 1243–1252, August 2, 2016may be relevant since hypoxia-inducible factor (HIF)-1a/b in-
duces the transcription of Glut1 and multiple rate-limiting glyco-
lytic enzymes to sustain glycolysis in activated T cells (Finlay
et al., 2012). We found that intrahepatic T cells showed an
increased expression of Glut1 ex vivo and that hypoxia during
antigenic stimulation in vitro could recapitulate this upregulation.
The liver can produce IL-7 in response to TLR signaling, thereby
enhancing T cell survival and function (Sawa et al., 2009); it is
plausible that this could be partially mediated by the capacity
of IL-7 to drive glycolysis through the induction of Glut1 (Loi-
sel-Meyer et al., 2012; Wofford et al., 2008). The metabolic
phenotype of HBV-specific T cells could, therefore, be a con-
sequence of, or an adaptation to, their target environment, allow-
ing the few remaining responses to survive.
In summary, our data show that different virus-specific T cells
in the same host have contrasting usage of pathways for glucose
metabolism. The exhausted T cell response directed against
HBV is characterized by an upregulation of the glucose trans-
porter Glut1, a dependency on glycolysis, and mitochondrial
defects in OXPHOS and depolarization. In contrast, the highly
functional CMV-specific T cell response can utilize OXPHOS
for effector function when glycolysis is blocked. Our finding
that a more protective T cell response requires mitochondrial
respiration is consistent with findings from two recent papers
emphasizing the importance of OXPHOS for antigen-specific
T cell expansion and antiviral immunity in mice (Okoye et al.,
2015; Sena et al., 2013). A better understanding of why this
pathway fails in exhausted T cells may reveal mitochondrial
targets for therapeutic boosting of antiviral immunity.
EXPERIMENTAL PROCEDURES
Patients
Ethics Statement
This study was approved by the ethical boards of the Royal Free Hospital and
Barts and The London NHS trust, and written informed consent was obtained
from all participants. All participants were HCV and HIV seronegative and HBV
treatment naive. HLA-A2 status was determined by specific antibody (AbD
Serotec). Patient information is provided in Table S1.
Overnight and Short-Term Cell Culture and Stimulation
PBMCs were isolated by Ficoll-Hypaque density gradient centrifugation and
either analyzed directly or cryopreserved. Liver biopsy sections, surplus to diag-
nostic requirements, were homogenized and filtered to obtain intrahepatic lym-
phocytes. To examine virus-specific T cell responses, PBMCs from HLA-A2+
donors were stimulated with 1 mM HBV-derived HLA-A2 restricted peptides
(core, FLPSDFFPSV; envelope, FLLTRILTI, WLSLLVPFV, LLVPFVQWFV, and
GLSPTVWLSV; polymerase, GLSRYVARL and KLHLYSHPI) (Proimmune) or
stained with dextramers loaded with the aforementioned peptides (Immudex).
If derived fromHLA-A2 donors, PBMCswere stimulatedwith 1 mg overlapping
peptides spanning the whole HBV core protein, with sequence correlating to
HBV genotype D (AYW) (JPT Peptide Technologies). Responses to CMV were
measured using 1 mMNLVPMVATV peptide (Proimmune) or dextramers (Immu-
dex) for HLA-A2+ donors or overlapping pp65 for HLA-A2 donors (JPT Peptide
Technologies). All cultures were supplemented with 20 U/ml rhIL-2 (Miltenyi
Biotech) at days 0 and 4 and with the addition of rhIL-12 (Miltenyi Biotech) at
10 ng/ml at day 0 where indicated. PBMCs were restimulated on day 9 for 4 hr
by re-addingpeptide at theoriginal concentration in thepresenceof 1mg/ml bre-
feldinA (BFA; Sigma-Aldrich). To assessmetabolic requirements, sampleswere
split and transferred into media containing either 10 mM glucose or 10 mM
galactose (supplementedwith1mMsodiumpyruvate)onday8 for24hr;peptide
and BFA were added for the final 4 hr. Virus-specific responses were identified
by IFNg or TNFa production.
Impact of Hypoxia
PBMCs were cultured and peptide stimulated as described earlier at normoxia
(21% 02). At the end of culture, PBMCs were split and peptide restimulated in
the presence of BFA overnight at 5%O2 (hypoxia) or 21%O2 (normoxia). Virus-
specific responses were identified by IFNg.
Flow Cytometric Analysis
PBMCs were stained for surface markers CD8 (OKT8) (eBiosciences), CD3
(UCHT1) (eBiosciences), PD-1 (EH12.2H7) (Biolegend), and CD38 (HIT2) (BD
Biosciences). Dead cells were always excluded using a live/dead fixable dye
staining kit (Invitrogen). Cells were fixed and permeabilized for detection of
intracellular molecules using anti-IFNg (B27), TNFa (MAB11) (BD Biosciences),
and Glut1 (202915) (RnD Systems). JC-1 (2 mM) (Molecular Probes), Mito-
Tracker Green (100 nM) (Invitrogen) were used per manufacturer’s instruc-
tions. Samples were acquired on a BD Fortess, analysis was performed using
FlowJo (Tree Star).
Metabolic Assay
OCR and ECAR were measured on an XF-24 Extracellular Flux Analyzer (Sea-
horse Bioscience). CD8 T cells were stimulated with 1 mg/ml CD3 (OKT3)
(eBiosciences) and 20 U/ml IL-2 in non-buffered RPMI 1640 medium during
the assay. Inhibitors were 1 mM oligomycin, 1.5 mM FCCP, 1 mM antimycin A
(Sigma Aldrich), and 100 nM rotenone (Seahorse Bioscience).Statistical Analysis
Statistical analyses were performed using the non-parametric Mann-Whitney
or Wilcoxon matched-pairs test as appropriate, and significant differences are
indicated in the figures (*p < 0.05; **p < 0.005; ***p < 0.0005).
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and one table and can be
foundwith this article online at http://dx.doi.org/10.1016/j.celrep.2016.06.078.
AUTHOR CONTRIBUTIONS
Conceptualization, A.S. andM.K.M.; Investigation, A.S., L.J.P., D.J., J.W., and
I.O.; Resources, U.S.G., N.H., P.T.K., E.N., R.G., and M.K.M.; Supervision,
A.S., C.F., S.M.H., and M.K.M.; Writing – Original Draft, A.S.; Writing – Review
and Editing, A.S. and M.K.M.; Funding Acquisition, M.K.M.
ACKNOWLEDGMENTS
A.S., J.W., and M.K.M. are funded by a Wellcome Trust Senior Investigator
Award (to M.K.M.); L.J.P. and M.K.M. are funded by MRC Project grant no.
MR/M020126/; I.O. is funded by an EASL post-doctoral fellowship; U.S.G. is
funded by the Wellcome Trust Clinical Research Training Fellowship; and
N.H. and P.T.K. are funded by a grant from Barts and The London Charity.
A.S. was also funded by a UCLH CIDC/NIHR Fast Track Grant, and D.J. was
funded by the Wolfson Foundation. We are very grateful to all the patients
who participated and all the staff who helped with recruitment.
Received: May 31, 2015
Revised: March 15, 2016
Accepted: June 17, 2016
Published: July 21, 2016
REFERENCES
Barber, D.L., Wherry, E.J., Masopust, D., Zhu, B., Allison, J.P., Sharpe, A.H.,
Freeman, G.J., and Ahmed, R. (2005). Restoring function in exhausted CD8
T cells during chronic viral infection. Nature 439, 682–687.
Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Di Vincenzo, P., Giuberti, T.,
Laccabue, D., Zerbini, A., Cavalli, A., Missale, G., et al. (2007). Characterization
of Hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection.
J. Virol. 81, 4215–4225.
Chang, C.-H., Curtis, J.D., Maggi, L.B., Jr., Faubert, B., Villarino, A.V.,
O’Sullivan, D., Huang, S.C.-C., van der Windt, G.J.W., Blagih, J., Qiu, J.,
et al. (2013). Posttranscriptional control of T cell effector function by aerobic
glycolysis. Cell 153, 1239–1251.
Ferrari, C. (2015). HBV and the immune response. Liver Int. 35 (Suppl. 1),
121–128.
Finlay, D.K., Rosenzweig, E., Sinclair, L.V., Feijoo-Carnero, C., Hukelmann,
J.L., Rolf, J., Panteleyev, A.A., Okkenhaug, K., and Cantrell, D.A. (2012).
PDK1 regulation ofmTORand hypoxia-inducible factor 1 integratemetabolism
and migration of CD8+ T cells. J. Exp. Med. 209, 2441–2453.
Fisicaro, P., Valdatta, C., Massari, M., Loggi, E., Biasini, E., Sacchelli, L.,
Cavallo, M.C., Silini, E.M., Andreone, P., Missale, G., et al. (2010). Antiviral in-
trahepatic T-cell responses can be restored by blocking programmed Death-1
pathway in chronic hepatitis B. Gastroenterology 138, 682–693, 693e1–693e4.
Henson, S.M., Lanna, A., Riddell, N.E., Franzese, O., Macaulay, R., Griffiths,
S.J., Puleston, D.J., Watson, A.S., Simon, A.K., Tooze, S.A., et al. (2014).
p38 signaling inhibits mTORC1-independent autophagy in senescent human
CD8+ T cells. J. Clin. Invest. 124, 4004–4016.
Jungermann, K., and Kietzmann, T. (2000). Oxygen: modulator of metabolic
zonation and disease of the liver. Hepatology 31, 255–260.
Khan, N., Shariff, N., Cobbold, M., Bruton, R., Ainsworth, J.A., Sinclair, A.J.,
Nayak, L., and Moss, P.A. (2002). Cytomegalovirus seropositivity drives theCell Reports 16, 1243–1252, August 2, 2016 1251
CD8 T cell repertoire toward greater clonality in healthy elderly individuals.
J. Immunol. 169, 1984–1992.
Loisel-Meyer, S., Swainson, L., Craveiro, M., Oburoglu, L., Mongellaz, C.,
Costa, C., Martinez, M., Cosset, F.L., Battini, J.L., Herzenberg, L.A., et al.
(2012). Glut1-mediated glucose transport regulates HIV infection. Proc. Natl.
Acad. Sci. USA 109, 2549–2554.
MacIver, N.J., Michalek, R.D., and Rathmell, J.C. (2013). Metabolic regulation
of T lymphocytes. Annu. Rev. Immunol. 31, 259–283.
Nebbia, G., Peppa, D., Schurich, A., Khanna, P., Singh, H.D., Cheng, Y.,
Rosenberg, W., Dusheiko, G., Gilson, R., ChinAleong, J., et al. (2012). Upregu-
lation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis
B virus infection. PLoS ONE 7, e47648.
Okoye, I., Wang, L., Pallmer, K., Richter, K., Ichimura, T., Haas, R., Crouse, J.,
Choi, O., Heathcote, D., Lovo, E., et al. (2015). The protein LEM promotes
CD8+ T cell immunity through effects on mitochondrial respiration. Science
350, 995–1001.
Patsoukis, N., Bardhan, K., Chatterjee, P., Sari, D., Liu, B., Bell, L.N., Karoly,
E.D., Freeman, G.J., Petkova, V., Seth, P., et al. (2015). PD-1 alters T-cell
metabolic reprogramming by inhibiting glycolysis and promoting lipolysis
and fatty acid oxidation. Nat. Commun. 6, 6692.
Pearce, E.L., and Pearce, E.J. (2013). Metabolic pathways in immune cell
activation and quiescence. Immunity 38, 633–643.
Pearce, E.L., Walsh, M.C., Cejas, P.J., Harms, G.M., Shen, H., Wang, L.S.,
Jones, R.G., and Choi, Y. (2009). Enhancing CD8 T-cell memory bymodulating
fatty acid metabolism. Nature 460, 103–107.
Sawa, Y., Arima, Y., Ogura, H., Kitabayashi, C., Jiang, J.J., Fukushima, T., Ka-
mimura, D., Hirano, T., andMurakami, M. (2009). Hepatic interleukin-7 expres-
sion regulates T cell responses. Immunity 30, 447–457.
Schurich, A., and Henson, S.M. (2014). The many unknowns concerning the
bioenergetics of exhaustion and senescence during chronic viral infection.
Front. Immunol. 5, 468.1252 Cell Reports 16, 1243–1252, August 2, 2016Schurich, A., Khanna, P., Lopes, A.R., Han, K.J., Peppa, D., Micco, L., Nebbia,
G., Kennedy, P.T.F., Geretti, A.-M., Dusheiko, G., et al. (2011). Role of the co-
inhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-prone CD8
T cells in persistent hepatitis B virus infection. Hepatology 53, 1494–1503.
Schurich, A., Pallett, L.J., Lubowiecki, M., Singh, H.D., Gill, U.S., Kennedy,
P.T., Nastouli, E., Tanwar, S., Rosenberg, W., andMaini, M.K. (2013). The third
signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific
CD8 T cells. PLoS Pathog. 9, e1003208.
Sena, L.A., Li, S., Jairaman, A., Prakriya, M., Ezponda, T., Hildeman, D.A.,
Wang, C.-R., Schumacker, P.T., Licht, J.D., Perlman, H., et al. (2013).
Mitochondria are required for antigen-specific T cell activation through reac-
tive oxygen species signaling. Immunity 38, 225–236.
Staron, M.M., Gray, S.M., Marshall, H.D., Parish, I.A., Chen, J.H., Perry, C.J.,
Cui, G., Li, M.O., and Kaech, S.M. (2014). The transcription factor FoxO1 sus-
tains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+)
T cells during chronic infection. Immunity 41, 802–814.
Utzschneider, D.T., Legat, A., Fuertes Marraco, S.A., Carrie´, L., Luescher, I.,
Speiser, D.E., and Zehn, D. (2013). T cells maintain an exhausted phenotype
after antigen withdrawal and population reexpansion. Nat. Immunol. 14,
603–610.
van der Windt, G.J.W., Everts, B., Chang, C.-H., Curtis, J.D., Freitas, T.C.,
Amiel, E., Pearce, E.J., and Pearce, E.L. (2012). Mitochondrial respiratory ca-
pacity is a critical regulator of CD8+ T cell memory development. Immunity 36,
68–78.
Virgin, H.W., Wherry, E.J., and Ahmed, R. (2009). Redefining chronic viral
infection. Cell 138, 30–50.
Wherry, E.J. (2011). T cell exhaustion. Nat. Immunol. 12, 492–499.
Wofford, J.A., Wieman, H.L., Jacobs, S.R., Zhao, Y., and Rathmell, J.C. (2008).
IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated acti-
vation of Akt to support T-cell survival. Blood 111, 2101–2111.
